Catalyst Wire Dossier Catalyst Wire Dossier

Xingnaojing

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Xingnaojing, covering 2008-11-24 to 2022-09-29. Get the full timeline:

Most recent: Clinical Trial Update: Analyzing the Pharmacodynamic Substances and the Effects of Xingnaojing for Mild-to-Severe Acute Ischemic Stroke [Phase 4]

See pricing